CAPHA PHARMACEUTICALS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | -99.00% |
|
-.--% | -.--% |
| Sales 2021 | - | Sales 2022 | - | Capitalization | 8.87K 740K |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 | - |
| Net Debt 2021 | 335K 27.95M | Net Debt 2022 | 415K 34.62M | EV / Sales 2022 | - |
| P/E ratio 2021 |
-0.15
x | P/E ratio 2022 |
-0.12
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 33.36% |
More Fundamentals
* Assessed data
More news
| 1 day | -99.00% |
3 years
0.00
0.00
5 years
0.000.00
10 years
0.000.25
| Managers | Title | Age | Since |
|---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 31/02/31 |
Janice Brown
BRD | Director/Board Member | - | 01/02/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
James Brown
CEO | Chief Executive Officer | - | 31/02/31 |
Janice Brown
BRD | Director/Board Member | - | 01/02/01 |
Herbert Leary
BRD | Director/Board Member | - | 25/10/25 |
Capha Pharmaceuticals Inc. is a Canada-based company. The Company is engaged in exploring various opportunities in the medical technology space.
Sector
Pharmaceuticals
Calendar
30/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 64 | |
| +25.83% | 661B | |
| +26.84% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +14.85% | 231B | |
| +5.23% | 200B | |
| -8.75% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- FPSUF Stock
